Candida albicans is a commensal yeast fungus of the human oral, gastrointestinal, and
genital mucosal surfaces, and skin. Antibiotic-induced dysbiosis, iatrogenic …

Candida albicans is a major fungal pathogen of humans. It exists as a commensal in the oral
cavity, gut or genital tract of most individuals, constrained by the local microbiota, epithelial …

Candida albicans, along with other closely related Candida species, are the primary
causative agents of vulvovaginal candidiasis (VVC)—a multifactorial infectious disease of …

Sialic acid sugar-carrying glycans, sialoglycans, are aberrantly expressed on many tumor
cells and have emerged as potent regulatory molecules involved in creating a tumor …

Immunomodulatory agents blocking the PD-1/PD-L1 pathway have shown a new way to
treat cancer. The explanation underlying the success of these agents may be the selective …

Vulvovaginal candidiasis (VVC) is a widespread vaginal infection primarily caused by
Candida albicans. VVC affects up to 75% of women of childbearing age once in their life …

Immunoglobulin (Ig) superfamily proteins play diverse roles in vertebrates, including
regulation of cellular responses by sensing endogenous or exogenous ligands. Siglecs are …

Sialic acid-binding Ig-like lectin 15 (Siglec-15) is an immune modulator and emerging
cancer immunotherapy target. However, limited understanding of its structure and …

Vulvovaginal candidiasis (VVC) is a symptomatic inflammation of the vagina mainly caused
by C. albicans. Other species, such as C. parapsilosis, C. glabrata, C. tropicalis, and C …

Vulvovaginal candidiasis (VVC) is experienced by an estimated 75% of women at least once
in their lifetime and is recurrent, defined as three or more infections per year (RVVC) in 5 …